Authors:
STUCKI M
SCHNORF J
HUSTINX H
GERBER H
LERCH PG
HALABI A
KLEINBLOESEM CH
MORELL A
Citation: M. Stucki et al., ANTI-D IMMUNOGLOBULIN IN RH(D) NEGATIVE VOLUNTEERS - CLEARANCE OF RH(D) POSITIVE RED-CELLS AND KINETICS OF SERUM ANTI-D LEVELS, Transfusion clinique et biologique, 5(3), 1998, pp. 180-188
Authors:
HOURIHADDAD Y
SOSKOLNE WA
HALABI A
SHAPIRA L
Citation: Y. Hourihaddad et al., THE SUBCUTANEOUS CHAMBER AS A MODEL FOR LOCAL INFLAMMATORY RESPONSE -MODULATION BY LOCAL AND SYSTEMIC IMMUNIZATION, European cytokine network, 9(3), 1998, pp. 46-46
Authors:
HOURIHADDAD Y
SOSKOLNE WA
HALABI A
SHAPIRA L
Citation: Y. Hourihaddad et al., MODULATION OF THE LOCAL INFLAMMATORY RESPONSE TO PORPHYROMONAS-GINGIVALIS IN SUBCUTANEOUS CHAMBERS BY IMMUNIZATION, Journal of dental research, 77, 1998, pp. 3191-3191
Authors:
SHAPIRA L
SOSKOLNE A
HALABI A
BARAK V
STABHOLZ A
Citation: L. Shapira et al., INDUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA AND INTERLEUKIN-1-BETA IN SUBCUTANEOUSLY IMPLANTED CHAMBER BY LIPOPOLYSACCHARIDE, Journal of endotoxin research, 4(5), 1997, pp. 325-329
Authors:
SHAPIRA L
HOURI Y
BARAK V
SOSKOLNE WA
HALABI A
STABHOLZ A
Citation: L. Shapira et al., TETRACYCLINE INHIBITS PORPHYROMONAS-GINGIVALIS LIPOPOLYSACCHARIDE-INDUCED LESIONS IN-VIVO AND TNF-ALPHA PROCESSING IN-VITRO, Journal of Periodontal Research, 32(1), 1997, pp. 183-188
Authors:
HOURIHADAD Y
SOSKOLNE WA
HALABI A
SHAPIRA L
Citation: Y. Hourihadad et al., ANIMAL CHAMBER MODEL FOR THE STUDY OF HOST-PARASITE INTERACTION IN PERIODONTAL-DISEASE, Journal of dental research, 76(5), 1997, pp. 1166-1166
Authors:
SHAPIRA L
SYLVIA VL
HALABI A
DEAN DD
BOYAN BD
SOSKOLNE WA
SCHWARTZ Z
Citation: L. Shapira et al., NONGENOMIC ACTIVATION OF PROTEIN-KINASE-C IN P-GINGIVALIS-LPS STIMULATED MACROPHAGES, Journal of dental research, 76, 1997, pp. 318-318
Authors:
DINGEMANSE J
KLEINBLOESEM CH
HALABI A
SCHNORF J
Citation: J. Dingemanse et al., PHARMACODYNAMICS OF IMMUNOGLOBULIN ANTI-D SD BY A CHALLENGE TEST IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 101-101
Authors:
SHAPIRA L
SYLVIA VL
HALABI A
SOSKOLNE WA
VANDYKE TE
DEAN DD
BOYAN BD
SCHWARTZ Z
Citation: L. Shapira et al., BACTERIAL LIPOPOLYSACCHARIDE INDUCES EARLY AND LATE ACTIVATION OF PROTEIN-KINASE-C IN INFLAMMATORY MACROPHAGES BY SELECTIVE ACTIVATION OF PKC-EPSILON, Biochemical and biophysical research communications, 240(3), 1997, pp. 629-634
Authors:
SHAPIRA L
HOURI Y
BARAK V
HALABI A
SOSKOLNE WA
STABHOLZ A
Citation: L. Shapira et al., HUMAN MONOCYTE RESPONSE TO CEMENTUM EXTRACTS FROM PERIODONTALLY DISEASED TEETH - EFFECT OF CONDITIONING WITH TETRACYCLINE, Journal of periodontology, 67(7), 1996, pp. 682-687
Authors:
SHAPIRA L
HALABI A
HOURI Y
SYLVIA V
BOYAN BD
SCHWARTZ Z
Citation: L. Shapira et al., P-GINGIVALIS LIPOPOLYSACCHARIDE (LPS) ACTIVATES PROTEIN-KINASE-C IN MOUSE MACROPHAGES, Journal of dental research, 75(5), 1996, pp. 1250-1250
Citation: L. Shapira et al., TETRACYCLINE INHIBITS LPS-GENERATED SUBCUTANEOUS LESION IN MICE IS RELATED TO CHE INHIBITION OF TNF-ALPHA PROCESSING, Journal of dental research, 75(5), 1996, pp. 1254-1254
Authors:
SHAPIRA L
SOSKOLNE WA
HOURI Y
BARAK V
HALABI A
STABHOLZ A
Citation: L. Shapira et al., PROTECTION AGAINST ENDOTOXIC-SHOCK AND LIPOPOLYSACCHARIDE-INDUCED LOCAL INFLAMMATION BY TETRACYCLINE - CORRELATION WITH INHIBITION OF CYTOKINE SECRETION, Infection and immunity, 64(3), 1996, pp. 825-828
Citation: H. Hinrichsen et al., CLINICAL ASPECTS OF CARDIOVASCULAR EFFECTS OF H-2-RECEPTOR ANTAGONISTS, Journal of clinical pharmacology, 35(2), 1995, pp. 107-116
Citation: A. Halabi et al., P-GINGIVALIS LPS INDUCES SPECIFIC PROTEIN-TYROSINE PHOSPHORYLATION INHUMAN MONOCYTES, Journal of dental research, 74(3), 1995, pp. 962-962
Authors:
HOURI Y
STABHOLZ A
HALABI A
SOSKOLNE A
BARAK V
SHAPIRA L
Citation: Y. Houri et al., MONOCYTE RESPONSE TO CEMENTUM EXTRACTS - EFFECT OF CONDITIONING WITH TETRACYCLINE, Journal of dental research, 74, 1995, pp. 548-548
Citation: H. Hinrichsen et al., CLINICAL ASPECTS OF CARDIOVASCULAR EFFECTS OF H-2-RECEPTOR ANTAGONISTS, European journal of clinical investigation, 25, 1995, pp. 47-56
Citation: A. Halabi et al., BUNAZOSIN IN PATIENTS WITH IMPAIRED HEPATIC OR RENAL-FUNCTION, European journal of drug metabolism and pharmacokinetics, 18(3), 1993, pp. 309-313
Citation: H. Hinrichsen et al., DOSE-DEPENDENT HEART-RATE REDUCING EFFECT OF NIZATIDINE, A HISTAMINE-H2-RECEPTOR ANTAGONIST, British journal of clinical pharmacology, 35(5), 1993, pp. 461-466
Citation: A. Halabi et W. Kirch, 24-HOUR HEMODYNAMIC-EFFECTS OF 2 DIFFERENT DIHYDROPYRIDINE DERIVATIVES ASSESSED BY NONINVASIVE METHODS IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, American journal of noninvasive cardiology, 7(3), 1993, pp. 180-185
Authors:
NOKHODIAN A
HALABI A
EBERT U
ALHAMDAN Y
KIRCH W
Citation: A. Nokhodian et al., INTERACTION OF RIFAMPICIN WITH BUNAZOSIN, AN ALPHA(1)-ADRENOCEPTOR ANTAGONIST, IN HEALTHY-VOLUNTEERS, Drug investigation, 6(6), 1993, pp. 362-364
Authors:
MESCHEDER A
HALABI A
NOKHODIAN A
ALHAMDAN Y
KIRCH W
Citation: A. Mescheder et al., ANTIHYPERTENSIVE ACTIVITY, CARDIAC-PERFORMANCE AND PHARMACOKINETICS OF BUNAZOSIN, A NOVEL ALPHA-1-ADRENOCEPTOR ANTAGONIST, IN PATIENTS WITHNORMAL AND IMPAIRED RENAL-FUNCTION, Drug investigation, 6(5), 1993, pp. 263-270
Citation: A. Mescheder et al., CHANGES IN THE EFFECTS OF NIZATIDINE AND FAMOTIDINE ON CARDIAC-PERFORMANCE AFTER PRETREATMENT WITH RANITIDINE, European Journal of Clinical Pharmacology, 45(2), 1993, pp. 151-156